These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20222987)

  • 1. Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.
    Schulman-Marcus J; Prabhakaran D; Gaziano TA
    BMC Cardiovasc Disord; 2010 Mar; 10():13. PubMed ID: 20222987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sixty-four-slice computed tomography of the coronary arteries: cost-effectiveness analysis of patients presenting to the emergency department with low-risk chest pain.
    Khare RK; Courtney DM; Powell ES; Venkatesh AK; Lee TA
    Acad Emerg Med; 2008 Jul; 15(7):623-32. PubMed ID: 19086322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).
    Goldstein P; Wiel E
    Minerva Anestesiol; 2005 Jun; 71(6):297-302. PubMed ID: 15886591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smartphone-based tele-electrocardiography support for primary care physicians reduces the pain-to-treatment time in acute coronary syndrome.
    Chauhan V; Negi PC; Raina S; Raina S; Bhatnagar M; Guleri R; Kanwar V; Pandey KS
    J Telemed Telecare; 2018 Sep; 24(8):540-546. PubMed ID: 28750576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care.
    Kip MMA; Koffijberg H; Moesker MJ; IJzerman MJ; Kusters R
    BMC Cardiovasc Disord; 2017 Aug; 17(1):213. PubMed ID: 28768475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of quantitative pretest probability intended to reduce unnecessary medical radiation exposure in emergency department patients with chest pain and dyspnea.
    Troyer JL; Jones AE; Shapiro NI; Mitchell AM; Hewer I; Kline JA
    Acad Emerg Med; 2015 May; 22(5):525-35. PubMed ID: 25899550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of telemetry for hospitalized patients with low-risk chest pain.
    Ward MJ; Eckman MH; Schauer DP; Raja AS; Collins S
    Acad Emerg Med; 2011 Mar; 18(3):279-86. PubMed ID: 21401791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of acute coronary syndrome in patients with normal electrocardiogram performed during presence or absence of chest pain.
    Turnipseed SD; Trythall WS; Diercks DB; Laurin EG; Kirk JD; Smith DS; Main DN; Amsterdam EA
    Acad Emerg Med; 2009 Jun; 16(6):495-9. PubMed ID: 19426294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac CT in the assessment of acute chest pain in the emergency department.
    Bastarrika G; Thilo C; Headden GF; Zwerner PL; Costello P; Schoepf UJ
    AJR Am J Roentgenol; 2009 Aug; 193(2):397-409. PubMed ID: 19620436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of the best method to predict acute coronary syndrome using only the electrocardiogram from the emergency department.
    Forberg JL; Green M; Björk J; Ohlsson M; Edenbrandt L; Ohlin H; Ekelund U
    J Electrocardiol; 2009; 42(1):58-63. PubMed ID: 18804783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study.
    Cowper PA; Pan W; Anstrom KJ; Kaul P; Wallentin L; Davidson-Ray L; Nikolic E; Janzon M; Levin LÅ; Cannon CP; Harrington RA; Mark DB
    J Am Coll Cardiol; 2015 Feb; 65(5):465-76. PubMed ID: 25660925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study.
    Nikolic E; Janzon M; Hauch O; Wallentin L; Henriksson M;
    Eur Heart J; 2013 Jan; 34(3):220-8. PubMed ID: 22719022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-hospital prediction of death or cardiovascular complications during hospitalisation and death within one year in suspected acute coronary syndrome patients.
    Thang ND; Karlson BW; Sundström BW; Karlsson T; Herlitz J
    Int J Cardiol; 2015 Apr; 185():308-12. PubMed ID: 25828671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
    Weintraub WS; Mahoney EM; Lamy A; Culler S; Yuan Y; Caro J; Gabriel S; Yusuf S;
    J Am Coll Cardiol; 2005 Mar; 45(6):838-45. PubMed ID: 15766816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
    Sculpher MJ; Lozano-Ortega G; Sambrook J; Palmer S; Ormanidhi O; Bakhai A; Flather M; Steg PG; Mehta SR; Weintraub W
    Am Heart J; 2009 May; 157(5):845-52. PubMed ID: 19376310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.